肠道菌群对胶质瘤的调控作用研究进展

doi:10.3969/j.issn.1006-5725.2024.14.021

Abstract

Abstract:

Glioma is the most common primary tumor of the brain， accounting for 81 % of central nervous system （CNS） malignant tumors. The degree of malignancy is high， and the current treatment methods are limited. In recent years， with the in-depth study of intestinal flora and brain-gut axis， it has been found that the diversity of gut microbiota plays an important role in the regulation of glioma. The mechanism is that the intestinal flora affects the development of glioma through the role of immune regulation and metabolites. In addition， it has been confirmed that there is a certain correlation between some probiotics and glioma， which provides a new application prospect for the treatment of glioma. This paper discusses the main intestinal bacteria that regulate gliomas as well as the role and regulatory mechanisms of intestinal flora in the development of gliomas， and provides ideas for the discovery of new targets for glioma treatment and further improvement of treatment options.

Key words: intestinal flora, glioma, brain-gut axis

CLC Number:

R739.41

Kexin XI,Yuqi ZHAO,Xiaoting XIE,Yuntao LU,Hongying FAN,Xiaoyan. HE. Research progress on the regulation of intestinal flora on glioma[J]. The Journal of Practical Medicine, 2024, 40(14): 2027-2030.

References 36

1	XU S， TANG L， LI X， et al. Immunotherapy for glioma：current management and future application［J］. Cancer Lett， 2020， 476：1-12. doi:10.1016/j.canlet.2020.02.002 doi: 10.1016/j.canlet.2020.02.002
2	GUSYATINER O， HEGI M E. Glioma epigenetics： From subclassification to novel treatment options［J］. Semin Cancer Biol， 2018， 51：50-58. doi:10.1016/j.semcancer.2017.11.010 doi: 10.1016/j.semcancer.2017.11.010
3	ESLAHI M， DANA P M， ASEMI Z， et al. The effects of chitosan-based materials on glioma： Recent advances in its applications for diagnosis and treatment［J］. Int J Biol Macromol， 2021，168：124-129. doi:10.1016/j.ijbiomac.2020.11.180 doi: 10.1016/j.ijbiomac.2020.11.180
4	姜海啸，曾巍，张恒柱，等. 肠道菌群及其代谢产物在胶质瘤中的调控机制研究进展［J］. 肿瘤预防与治疗， 2022，35（4）：388-392. doi:10.3969/j.issn.1674-0904.2022.04.013 doi: 10.3969/j.issn.1674-0904.2022.04.013
5	MA P J， WANG M M， WANG Y. Gut microbiota： A new insight into lung diseases［J］. Biomed Pharmacother， 2022，155：113810. doi:10.1016/j.biopha.2022.113810 doi: 10.1016/j.biopha.2022.113810
6	BIDELL M R， HOBBS A L V， LODISE T P. Gut microbiome health and dysbiosis： A clinical primer［J］. Pharmacotherapy， 2022， 42（11）：849-857. doi:10.1002/phar.2731 doi: 10.1002/phar.2731
7	QUAGLIO A E V， GRILLO T G， DE OLIVEIRA E C S， et al. Gut microbiota， inflammatory bowel disease and colorectal cancer［J］. World J Gastroenterol， 2022， 28（30）：4053-4060. doi:10.3748/wjg.v28.i30.4053 doi: 10.3748/wjg.v28.i30.4053
8	LONG Y， TANG L， ZHOU Y， et al. Causal relationship between gut microbiota and cancers： a two-sample Mendelian randomisation study［J］. BMC Med， 2023，21（1）：66. doi:10.1186/s12916-023-02761-6 doi: 10.1186/s12916-023-02761-6
9	MANOS J. The human microbiome in disease and pathology［J］. APMIS， 2022，130（12）：690-705. doi:10.1111/apm.13225 doi: 10.1111/apm.13225
10	OSADCHIY V， MARTIN C R， MAYER E A. The Gut-Brain Axis and the Microbiome： Mechanisms and Clinical Implications［J］. Clin Gastroenterol Hepatol， 2019， 17（2）：322-332. doi:10.1016/j.cgh.2018.10.002 doi: 10.1016/j.cgh.2018.10.002
11	YIN Y， GUO Q， ZHOU X， et al. Role of brain-gut-muscle axis in human health and energy homeostasis［J］. Front Nutr， 2022， 9：947033. doi:10.3389/fnut.2022.947033 doi: 10.3389/fnut.2022.947033
12	FLANNONE L F， GOMEZ-EGUILAZ M， DE CARO C. Gut microbiota manipulation as an epilepsy treatment［J］. Neurobiol Dis， 2022，174：105897. doi:10.1016/j.nbd.2022.105897 doi: 10.1016/j.nbd.2022.105897
13	LYU Y， YANG H， CHEN L. Metabolic regulation on the immune environment of glioma through gut microbiota［J］. Semin Cancer Biol， 2022， 86（Pt 2）：990-997. doi:10.1016/j.semcancer.2021.05.005 doi: 10.1016/j.semcancer.2021.05.005
14	刘树昕，吴爱娟，甄妮，等. 广谱抑菌乳酸菌的筛选及其细菌素相关基因分析［J］. 食品科学， 2020，41（6）：101-107.
15	DONO A， NICKLES J， RODRIGUEZ-ARMENDARIZ A G， et al. Glioma and the gut-brain axis： opportunities and future perspectives［J］. Neurooncol Adv， 2022，4（1）：vdac054. doi:10.1093/noajnl/vdac054 doi: 10.1093/noajnl/vdac054
16	HOU X， DU H， DENG Y， et al. Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma［J］. J Transl Med， 2023，21（1）：198. doi:10.1186/s12967-023-04042-5 doi: 10.1186/s12967-023-04042-5
17	PATRIZZ A， DONO A， ZOROFCHIAN S， et al. Glioma and temozolomide induced alterations in gut microbiome［J］. Sci Rep， 2020，10（1）：21002. doi:10.1038/s41598-020-77919-w doi: 10.1038/s41598-020-77919-w
18	D'AlESSANDRO G， LAURO C， QUAGLIO D， et al. Neuro-Signals from Gut Microbiota： Perspectives for Brain Glioma［J］. Cancers （Basel）， 2021，13（11）：2810. doi:10.3390/cancers13112810 doi: 10.3390/cancers13112810
19	DONO A， NICKLES J， RODRIGUEZ-ARMENDARIZ A G， et al. Glioma and the gut-brain axis： opportunities and future perspectives［J］. Neurooncol Adv， 2022，4（1）：vdac054. doi:10.1093/noajnl/vdac054 doi: 10.1093/noajnl/vdac054
20	FAN Y， SU Q， CHEN J， et al. Gut Microbiome Alterations Affect Glioma Development and Foxp3 Expression in Tumor Microenvironment in Mice［J］. Front Onco， 2022，12：836953. doi:10.3389/fonc.2022.836953 doi: 10.3389/fonc.2022.836953
21	YOSHIKAWA S， TANIGUCHIi K， SAWAMURA H， et al. Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma［J］. Explor Target Antitumor Ther， 2022，3（6）：817-827.
22	GOPALAKRISHNAN V， HELMINK B A， SPENCER C N， et al. The Influence of the Gut Microbiome on Cancer， Immunity， and Cancer Immunotherapy［J］. Cancer Cell， 2018，33（4）：570-580. doi:10.1016/j.ccell.2018.03.015 doi: 10.1016/j.ccell.2018.03.015
23	ZHU J， SU J. Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy［J］. Indian J Microbiol， 2022，62（1）：23-31. doi:10.1007/s12088-021-00962-2 doi: 10.1007/s12088-021-00962-2
24	ZHANG X， ZHAO L， ZHANG H， et al. The immunosuppressive microenvironment and immunotherapy in human glioblastoma［J］. Front Immunol， 2022，13：1003651. doi:10.3389/fimmu.2022.1003651 doi: 10.3389/fimmu.2022.1003651
25	LIANG J， LI T， ZHAO J， et al. Current understanding of the human microbiome in glioma［J］. Front Oncol， 2022，12：781741. doi:10.3389/fonc.2022.781741 doi: 10.3389/fonc.2022.781741
26	QIU Q， LIN Y， MA Y， et al. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy［J］. Front Immunol， 2021，11：612202. doi:10.3389/fimmu.2020.612202 doi: 10.3389/fimmu.2020.612202
27	何宝坤. 基于肠道菌群发现用于治疗Treg缺失免疫缺陷病的新药［J］. 中国药理学与毒理学杂志， 2019，33（9）：750.
28	KAZMIERCZAK-SIEDLECKA K， MARANO L， MEROLA E， et al. Sodium butyrate in both prevention and supportive treatment of colorectal cancer［J］. Front Cell Infect Microbiol， 2022，12：1023806. doi:10.3389/fcimb.2022.1023806 doi: 10.3389/fcimb.2022.1023806
29	Al-QADAMI G H， SECOMBE K R， SUBRAMANIAM C B， et al. Gut Microbiota-Derived Short-Chain Fatty Acids： Impact on Cancer Treatment Response and Toxicities［J］. Microorganisms， 2022，10（10）：2048. doi:10.3390/microorganisms10102048 doi: 10.3390/microorganisms10102048
30	MA X， MA L， WANG Z， et al. Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis-A Pilot Study［J］. Front Neurol， 2020， 11：585977. doi:10.3389/fneur.2020.585977 doi: 10.3389/fneur.2020.585977
31	XIONG R G， ZHOU D D， WU S X， et al. Health Benefits and Side Effects of Short-Chain Fatty Acids［J］. Foods， 2022，11（18）：2863. doi:10.3390/foods11182863 doi: 10.3390/foods11182863
32	WANG L， LI S， FAN H， et al. Bifidobacterium lactis combined with Lactobacillus plantarum inhibit glioma growth in mice through modulating PI3K/AKT pathway and gut microbiota［J］. Front Microbiol， 2022，13：986837. doi:10.3389/fmicb.2022.986837 doi: 10.3389/fmicb.2022.986837
33	LI X C， WU B S， JIANG Y， et al. Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma［J］. Drug Des Devel Ther， 2021，15：1641-1652. doi:10.2147/dddt.s298261 doi: 10.2147/dddt.s298261
34	JIANG H， ZENG W， ZHANG X， et al. The role of gut microbiota in patients with benign and malignant brain tumors： a pilot study［J］. Bioengineered， 2022，13（3）：7847-7859. doi:10.1080/21655979.2022.2049959 doi: 10.1080/21655979.2022.2049959
35	ŁANIEWSKI P， ILHAN Z E， HERBST-KRALOVETZ M M. The microbiome and gynaecological cancer development， prevention and therapy［J］. Nat Rev Urol， 2020，17（4）：232-250. doi:10.1038/s41585-020-0286-z doi: 10.1038/s41585-020-0286-z
36	SI W， LIANG H， BUGNO J， et al. Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade［J］. Gu， 2022，71（3）：521-533. doi:10.1136/gutjnl-2020-323426 doi: 10.1136/gutjnl-2020-323426

[1]	Shihe XIAO,Gang LI,Zhonghai LIU,Zhen. LIU. Expression of ZEB2 and CCL20 in glioma tissue and their correlation with prognosis [J]. The Journal of Practical Medicine, 2024, 40(9): 1262-1267.
[2]	Nan LI,Xue ZHAO, A′nali,Heran LIANG,Na. GE. Research progress on the role of bile acids in alcoholic liver disease [J]. The Journal of Practical Medicine, 2024, 40(15): 2187-2193.
[3]	Hua JIANG,Limin ZHANG,Dan WANG,Ping HAN,Yuehong SUN,Yuwen LI,Chenxi ZHANG,Wencan JIANG,Xiao LI,Hui. ZHAO. Clinical value of joint detection of cerebrospinal fluid and blood routine indicators in differentiating between multiple gliomas and primary central nervous system lymphoma [J]. The Journal of Practical Medicine, 2024, 40(13): 1864-1868.
[4]	Yanwei HUANG,Kaitai ZENG,Ziqi WEN,Yan LI,Rongping. CHEN. Markers of gut flora in Parkinson′s disease： A literature review [J]. The Journal of Practical Medicine, 2024, 40(11): 1473-1478.
[5]	Xinwen BI,Yuanjie CUI,Qiuxian LU,Jia CUI,Fan BU,Fang HE,Hua YANG,Ming. LI. Immunomodulatory effects of intestinal flora on glucose and lipid metabolism disorders in high⁃fat diet induced obese mice [J]. The Journal of Practical Medicine, 2024, 40(11): 1505-1512.
[6]	Qi ZHANG,Jia HU,Hui LI,Jin WANG,Zhongde LI,Zhiyuan. HU. Correlations of miR⁃203a⁃3p and PHOX2B expression in glioma tissues with clinical features and prognosis [J]. The Journal of Practical Medicine, 2024, 40(10): 1382-1388.
[7]	LI Mengxin, HUI Lei, JI Qiankun, WANG Shuren, LI Haiming, JIN Baozhe.. ANXA1 is upregulated in glioblastoma and promoting malignant progression of glioblastoma [J]. The Journal of Practical Medicine, 2023, 39(8): 928-935.
[8]	Xianda CHEN, Nan MA, Shengjie GUO, Zhenhua LIU, Kai. YAO. Efficacy and safety of anlotinib monotherapy and combinated therapy in the treatment of advanced pheochromocytoma/paraganglioma [J]. The Journal of Practical Medicine, 2023, 39(23): 3106-3110.
[9]	Yuanjian LIAO,Jingjing YAO,Mingshun ZUO,Hongchuan CHEN,Te XU,Neng. ZHANG. Progress in genetic research on metastatic pheochromocytoma and paraganglioma [J]. The Journal of Practical Medicine, 2023, 39(23): 3137-3142.
[10]	Ming LI,Wei SU,Shiheng. MA. Analyze of the value of bifidum in the treatment of sepsis caused by pulmonary infection based on intestinal immunity [J]. The Journal of Practical Medicine, 2023, 39(18): 2384-2388.
[11]	Hua PAN,Minshang ZHANG,Xu WANG,Dandan. JIANG. Effect of Qi Chang Xue Xing Tang retention enema combined with heat sensitive moxibustion on gastrointestinal function and immune function of patients after radical gastrectomy [J]. The Journal of Practical Medicine, 2023, 39(16): 2130-2135.
[12]	GUO Yansong, LI Sirou, LI Lin, ZENG Zhaomu, BAI Zetong, WEN Xichao, ZHENG Kebin. . Research progress of m6A modification in glioma [J]. The Journal of Practical Medicine, 2023, 39(13): 1724-1728.
[13]	MA Jun, XIANG Mei. . Effects of lidocaine on the malignant biological behavior of glioma cells through SHH/GLI signaling pathway [J]. The Journal of Practical Medicine, 2023, 39(11): 1403-1408.
[14]	LEI Yu, HU Yaxin, YU Lei, CHENG Mingliang, CHENG Zhuo, CONG Shuo, PU Qian, ZHENG Lin. . Effect of intrahepatic cholestasis on bile acid spectrum and intestinal flora in ileocecum of mice [J]. The Journal of Practical Medicine, 2023, 39(10): 1232-1236.
[15]	ZHANG Chenchen, YU Meiling, TAN Weiguo, WU Zhuhua, WEI Wenjing. . Effects of Mycobacterium tuberculosis infection and conventional anti⁃tuberculosis chemotherapy on gut mi⁃ crobiota [J]. The Journal of Practical Medicine, 2022, 38(6): 678-684.

Research progress on the regulation of intestinal flora on glioma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 36

Related Articles 15

Recommended Articles

Metrics

Comments